JP4402176B2 - 新規アミド化合物及びこれを含有する医薬 - Google Patents

新規アミド化合物及びこれを含有する医薬 Download PDF

Info

Publication number
JP4402176B2
JP4402176B2 JP52814599A JP52814599A JP4402176B2 JP 4402176 B2 JP4402176 B2 JP 4402176B2 JP 52814599 A JP52814599 A JP 52814599A JP 52814599 A JP52814599 A JP 52814599A JP 4402176 B2 JP4402176 B2 JP 4402176B2
Authority
JP
Japan
Prior art keywords
group
compound
pyridyl
methyl
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP52814599A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO1999025712A1 (ja
Inventor
公幸 渋谷
徹 三浦
勝巳 川峯
幸広 佐藤
忠明 扇谷
崇博 北村
千代香 尾崎
敏行 枝野
光輝 平田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of JPWO1999025712A1 publication Critical patent/JPWO1999025712A1/ja
Application granted granted Critical
Publication of JP4402176B2 publication Critical patent/JP4402176B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP52814599A 1997-11-14 1998-11-16 新規アミド化合物及びこれを含有する医薬 Expired - Fee Related JP4402176B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP33087797 1997-11-14
JP9-330877 1997-11-14
PCT/JP1998/005149 WO1999025712A1 (en) 1997-11-14 1998-11-16 Novel amide compounds and drugs containing the same

Publications (2)

Publication Number Publication Date
JPWO1999025712A1 JPWO1999025712A1 (ja) 2001-03-27
JP4402176B2 true JP4402176B2 (ja) 2010-01-20

Family

ID=18237521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52814599A Expired - Fee Related JP4402176B2 (ja) 1997-11-14 1998-11-16 新規アミド化合物及びこれを含有する医薬

Country Status (10)

Country Link
EP (1) EP0979823B1 (de)
JP (1) JP4402176B2 (de)
AT (1) ATE321759T1 (de)
AU (1) AU755654C (de)
CA (1) CA2303781A1 (de)
DE (1) DE69834052T2 (de)
ES (1) ES2262248T3 (de)
HU (1) HUP0000729A3 (de)
TW (1) TW580498B (de)
WO (1) WO1999025712A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969711B2 (en) 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
WO1998054153A1 (en) * 1997-05-26 1998-12-03 Kowa Company, Ltd. Novel cyclic diamine compounds and medicine containing the same
ATE257826T1 (de) 1999-06-28 2004-01-15 Fuji Photo Film Co Ltd Benzimidazolderivate und sie enthaltende medikamente
EP1201664B1 (de) 1999-06-30 2004-09-08 Fuji Photo Film Co., Ltd. Bemzimidazolverbindungen und medikamente die diese enthalten
JP4624616B2 (ja) * 1999-07-07 2011-02-02 富士フイルム株式会社 ベンズイミダゾール化合物
AU2003243921B2 (en) 2002-06-27 2009-05-07 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
PT1723128E (pt) 2004-01-06 2013-02-27 Novo Nordisk As Heteroaril-ureias e o seu uso como activadores da glicoquinase
US8916550B2 (en) 2005-05-09 2014-12-23 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
AU2006244074B2 (en) * 2005-05-09 2012-12-13 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
KR20080024211A (ko) 2005-07-08 2008-03-17 노보 노르디스크 에이/에스 디시클로알킬 우레아 글루코키나제 활성제
JP2009500378A (ja) 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
BRPI0612996A2 (pt) 2005-07-14 2010-12-14 Novo Nordisk As ativadores de urÉia glucocinase
US8138185B2 (en) 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
AU2008204530B2 (en) 2007-01-11 2013-08-01 Vtv Therapeutics Llc Urea glucokinase activators
AU2019287437A1 (en) 2018-06-12 2020-09-10 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2021167840A1 (en) 2020-02-18 2021-08-26 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof
CN116194442A (zh) 2020-06-08 2023-05-30 维特卫治疗有限责任公司 {2-[3-环己基-3-(反式-4-丙氧基-环己基)-脲基]-噻唑-5-基硫烷基}-乙酸的盐或共晶体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116433B1 (de) * 1968-04-01 1976-05-24 Fujisawa Pharmaceutical Co
JPS6242989A (ja) * 1986-08-04 1987-02-24 Sumitomo Pharmaceut Co Ltd 溶接電極の自動整形および交換装置
JPH04139172A (ja) * 1990-10-01 1992-05-13 Sankyo Co Ltd α―スルフィニル置換アセトアミド誘導体
US5358946A (en) * 1992-05-29 1994-10-25 The Du Pont Merck Pharmaceutical Company Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis
JP4191269B2 (ja) * 1996-05-17 2008-12-03 興和株式会社 新規なアニリド化合物及びこれを含有する医薬

Also Published As

Publication number Publication date
AU755654B2 (en) 2002-12-19
TW580498B (en) 2004-03-21
ATE321759T1 (de) 2006-04-15
EP0979823A1 (de) 2000-02-16
ES2262248T3 (es) 2006-11-16
CA2303781A1 (en) 1999-05-27
DE69834052T2 (de) 2006-11-02
HUP0000729A2 (hu) 2001-04-28
AU755654C (en) 2007-03-29
HUP0000729A3 (en) 2001-06-28
AU1053899A (en) 1999-06-07
EP0979823B1 (de) 2006-03-29
DE69834052D1 (de) 2006-05-18
WO1999025712A1 (en) 1999-05-27
EP0979823A4 (de) 2002-10-30

Similar Documents

Publication Publication Date Title
JP3614865B2 (ja) 新規な環状ジアミン化合物及びこれを含有する医薬
JPWO1998054153A1 (ja) 新規な環状ジアミン化合物及びこれを含有する医薬
EP0979823B1 (de) Neue amidverbindungen und medikamente die diese enthalten
JP7692353B2 (ja) マトリプターゼ２阻害剤及びその使用
JP2021508686A (ja) Ｌｐａアンタゴニストとしてのトリアゾールｎ結合カルバモイルシクロヘキシル酸
JP2021507896A (ja) Ｌｐａアンタゴニストとしてのイソキサゾールｎ結合カルバモイルシクロヘキシル酸
JP2022500470A (ja) Ｌｐａアンタゴニストとしてのシクロペンチル酸
JPWO1999025712A1 (ja) 新規アミド化合物及びこれを含有する医薬
JP2010520162A (ja) ステアロイル−ＣｏＡデサチュラーゼ阻害剤であるチアジアゾール誘導体
JP4191269B2 (ja) 新規なアニリド化合物及びこれを含有する医薬
US6969711B2 (en) Cyclic diamine compounds and medicine containing the same
WO2013151877A1 (en) Pyrimidinedione carboxamide inhibitors of endothelial lipase
JP4647726B2 (ja) 新規なアニリド化合物及びこれを含有する医薬
JPWO1998042680A1 (ja) 新規なアニリド化合物及びこれを含有する医薬
JP2021533085A (ja) タンキラーゼ阻害剤としての１，２，４−トリアゾール誘導体
US7393866B2 (en) Amide compounds and medications containing the same
WO2007025775A2 (en) Cysteine protease inhibitors
US5158950A (en) 1,3-dithiol-2-ylidene derivatives and process for the preparation thereof
JPH0971570A (ja) ピリミジン誘導体及びこれを含有する医薬
GB2640329A (en) Hedgehog acyltransferase inhibitors
WO2015105749A1 (en) Sulfone amide linked benzothiazole inhibitors of endothelial lipase
JP2023532593A (ja) トリアゾール誘導体及びタンキラーゼ阻害剤としてのそれらの使用。
KR20020022766A (ko) 벤즈 이미다졸 화합물
WO2003087074A1 (en) Phenol compound, process for producing the same, and intermediate therefor
MXPA99010959A (es) Compuestos novedosos de diamina ciclica y medicina que contiene los mismos

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090210

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090410

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090908

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091027

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091029

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121106

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees